Skip to main content
Natalia Neparidze, MD, Oncology, North Haven, CT, Yale-New Haven Hospital

NataliaNeparidzeMD

Oncology North Haven, CT

Hematologic Oncology

Associate Professor Research DART Leader, Multiple Myeloma and Gammopathies Program Section of Hematology/Department of Internal Medicine and Yale Cancer Center Yale University School of Medicine

Dr. Neparidze is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Neparidze's full profile

Already have an account?

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 2004 - 2007
  • "Aieti" Highest Medical School
    "Aieti" Highest Medical SchoolClass of 2000

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2010 - 2024
  • CT State Medical License
    CT State Medical License 2008 - 2024
  • NY State Medical License
    NY State Medical License 2010 - 2015
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Patterns of Care and Clinical Outcomes with 7+3 Induction Chemotherapy for Patients (pts) with Acute Myeloid Leukemia (AML) in the United States (US): A Large Populati...
    Natalia Neparidze, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Trial in Progress: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in ...
    Natalia Neparidze, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience
    Natalia Neparidze, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Professional Memberships

Hospital Affiliations